Warburg Pincus & Co

Director, 10% owner at SHC; Director, 10% owner at ALHC; 10% owner at AVALARA INC, and 14 more

Sold, on record
$2.2B
Dollars the filings state
Form 4 sales
21
Latest Sep 5, 2025
Form 144 notices
0
Proposed sales
Companies
17
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ARUnusual
    Nov 8 2018

    Sold 5,194 shares at $15.87 ($82k)

    Warburg Pincus & Co., Director, 10% owner

    Sold 100% of holdings ($82k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TRTN-PAUnusual
    Mar 19 +131 days

    Sold 7.1M shares at $31.10 ($222M)

    Warburg Pincus & Co., Director

    Sold 100% of holdings ($222M position)0 shares leftFiling

  3. 3 Form 4 sale Silk Road Medical IncPlan not stated
    Apr 8 +20 days

    Sold 900,000 shares at $20.00 ($18M)

    Warburg Pincus & Co., 10% owner

    Sold 6.9% of holdings ($262M position)12.2M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale AVALARA INCUnusual
    May 20 +42 days

    Sold 4.4M shares at $69.63 ($306M)

    Warburg Pincus & Co., 10% owner

    Sold 47.5% of holdings ($645M position)4.9M shares leftFirst sale on recordFiling

  5. 5 Form 4 sale ALHCPlan not stated
    Apr 6 +687 days

    Sold 716,624 shares at $16.83 ($12.1M)

    Warburg Pincus & Co., Director, 10% owner

    Sold 2.8% of holdings ($429M position)24.8M shares leftFirst sale on recordFiling

  6. 6 Form 4 sale ALHCPlan not stated
    Sep 20 +532 days

    Sold 2M shares at $14.61 ($29.9M)

    Warburg Pincus & Co., Director, 10% owner

    Sold 10.2% of holdings ($292M position)17.9M shares leftFiling

  7. 7 Form 4 sale SHCNo plan
    Mar 4 +531 days

    Sold 16.6M shares at $14.31 ($237M)

    Warburg Pincus & Co., Director, 10% owner

    No 10b5-1 planSold 15.7% of holdings ($1.5B position)88.8M shares leftFirst sale on recordFiling

  8. 8 Form 4 sale SHCNo plan
    Sep 5 +550 days

    Sold 12M shares at $15.11 ($181M)

    Warburg Pincus & Co., Director, 10% owner

    No 10b5-1 planSold 16.3% of holdings ($1.1B position)61.8M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (21)

Form 144 notices and Form 4 sales by Warburg Pincus & Co
Source
Sep 5, 2025SHCDirector, 10% ownerForm 4 sale12M$181M16.3%No planSEC
Mar 4, 2024SHCDirector, 10% ownerForm 4 sale16.6M$237M15.7%No planSEC
Sep 20, 2022ALHCDirector, 10% ownerForm 4 sale2M$29.9M10.2%Plan not statedSEC
Apr 6, 2021ALHCDirector, 10% ownerForm 4 sale716,624$12.1M2.8%Plan not statedSEC
May 20, 2019AVALARA INC10% ownerForm 4 sale4.4M$306M47.5%UnusualSEC
Apr 8, 2019Silk Road Medical Inc10% ownerForm 4 sale900,000$18M6.9%Plan not statedSEC
Mar 19, 2019TRTN-PADirectorForm 4 sale7.1M$222M100.0%UnusualSEC
Nov 8, 2018ARDirector, 10% ownerForm 4 sale5,194$82k100.0%UnusualSEC
Sep 5, 2018TRTN-PADirectorForm 4 sale1.9M$64.3M19.9%Plan not statedSEC
Nov 21, 2017Bridgepoint Education IncDirector, 10% ownerForm 4 sale7.6M$59.7M100.0%UnusualSEC
Jul 31, 2015BLDR10% ownerForm 4 sale4.6M$56.2M18.5%Plan not statedSEC
May 27, 2015ARMK10% ownerForm 4 sale7.5M$236M53.5%UnusualSEC
Mar 11, 2015Endurance International Group Holdings, Inc.Director, 10% ownerForm 4 sale9.1M$172M41.9%UnusualSEC
Jun 4, 2014ARMKDirector, 10% ownerForm 4 sale5.1M$126M12.6%Plan not statedSEC
Jul 16, 2013Hana Biosciences IncDirector, 10% ownerForm 4 sale152M$9.1M100.0%UnusualSEC
Apr 26, 2011TRGP10% ownerForm 4 sale4.1M$129M29.4%UnusualSEC
Mar 23, 2011Polypore International, Inc.Director, 10% ownerForm 4 sale2.1M$110M40.8%UnusualSEC
Jul 16, 2009VIRX10% ownerForm 4 sale177,220$54k4.6%Plan not statedSEC
Apr 20, 2009Altus Pharmaceuticals Inc.10% ownerForm 4 sale785,122$165k30.5%UnusualSEC
Mar 20, 2006TDG10% ownerForm 4 sale821,594$17.3M2.6%Plan not statedSEC
Feb 17, 2006KNOLL INC10% ownerForm 4 sale13M$239M43.5%UnusualSEC